Cell Growth & Differentiation, Vol 2, Issue 8 373-378, Copyright © 1991 by American Association of Cancer Research

ARTICLES

Alternate splicing of mRNAs encoding human mast cell growth factor and localization of the gene to chromosome 12q22-q24

DM Anderson, DE Williams, R Tushinski, S Gimpel, J Eisenman, LA Cannizzaro, M Aronson, CM Croce, K Huebner and D Cosman
Department of Molecular Biology, Immunex Research and Development Corporation, Seattle, Washington 98101.

Human mast cell growth factor (MGF) complementary DNAs (cDNAs) were cloned from HeLa cells using the polymerase chain reaction with oligonucleotides corresponding to murine and human MGF sequences. Sequencing of the cloned human MGF polymerase chain reaction products revealed two types of cDNA: a full length form corresponding in size to the murine cDNA, and an alternately spliced clone with a deletion of the sixth exon of the gene. Since membrane-bound MGF is predicted to be proteolytically cleaved within the sequences encoded by exon 6 to generate a soluble protein, this alternately spliced cDNA would likely encode a noncleavable, membrane-bound form of MGF. No difference in biological activity on human bone marrow cells was observed with recombinant, soluble forms of both types of human MGF protein. Our previous localization of the murine MGF gene to the Sl locus on chromosome 10 suggested (via conserved linkage groups) that the human MGF gene would be located on human chromosome 12. Therefore, rodent-human somatic cell hybrids with or without an entire human chromosome 12 and hybrids retaining partial 12 were tested by Southern blot analysis and used to show the presence of the human Mgf locus at chromosome region 12q. Chromosomal in situ hybridization localized the gene to 12q22-q24 in the region predicted by the comparative mapping of the murine Mgf/Sl locus.

This article has been cited by other articles:

				W. Zhang, G. Stoica, S. I. Tasca, K. A. Kelly, and C. J. Meininger Modulation of Tumor Angiogenesis by Stem Cell Factor Cancer Res., December 1, 2000; 60(23): 6757 - 6762. [Abstract] [Full Text]

				H. Hakovirta, W. Yan, M. Kaleva, F. Zhang, K. Vänttinen, P. L. Morris, M. Söder, M. Parvinen, and J. Toppari Function of Stem Cell Factor as a Survival Factor of Spermatogonia and Localization of Messenger Ribonucleic Acid in the Rat Seminiferous Epithelium Endocrinology, March 1, 1999; 140(3): 1492 - 1498. [Abstract] [Full Text]

				O. Kassel, F. Schmidlin, C. Duvernelle, F. de Blay, and N. Frossard Up- and Down-Regulation by Glucocorticoids of the Constitutive Expression of the Mast Cell Growth Factor Stem Cell Factor by Human Lung Fibroblasts in Culture Mol. Pharmacol., December 1, 1998; 54(6): 1073 - 1079. [Abstract] [Full Text]

				J. Povey, N. Weeratunge, C. Marden, A. Sehgal, A. Thrasher, and C. Casimir Enhanced Retroviral Transduction of 5-Fluorouracil-Resistant Human Bone Marrow (Stem) Cells Using a Genetically Modified Packaging Cell Line Blood, December 1, 1998; 92(11): 4080 - 4089. [Abstract] [Full Text] [PDF]

				T. Kunisada, S.-Z. Lu, H. Yoshida, S. Nishikawa, S.-i. Nishikawa, M. Mizoguchi, S.-i. Hayashi, L. Tyrrell, D. A. Williams, X. Wang, et al. Murine Cutaneous Mastocytosis and Epidermal Melanocytosis Induced by Keratinocyte Expression of Transgenic Stem Cell Factor J. Exp. Med., May 18, 1998; 187(10): 1565 - 1573. [Abstract] [Full Text] [PDF]

				S. D. Lyman and S. E. W. Jacobsen c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities Blood, February 15, 1998; 91(4): 1101 - 1134. [Full Text] [PDF]

				V. C. Broudy Stem Cell Factor and Hematopoiesis Blood, August 15, 1997; 90(4): 1345 - 1364. [Full Text] [PDF]

				B. J. Longley, G. S. Morganroth, L. Tyrrell, T. G. Ding, D. M. Anderson, D. E. Williams, and R. Halaban Altered Metabolism of Mast-Cell Growth Factor (c-kit Ligand) in Cutaneous Mastocytosis N. Engl. J. Med., May 6, 1993; 328(18): 1302 - 1307. [Abstract] [Full Text]

				C I Brannan, M A Bedell, J L Resnick, J J Eppig, M A Handel, D E Williams, S D Lyman, P J Donovan, N A Jenkins, and N G Copeland Developmental abnormalities in Steel17H mice result from a splicing defect in the steel factor cytoplasmic tail. Genes & Dev., October 1, 1992; 6(10): 1832 - 1842. [Abstract] [PDF]